Creative Medical Technology NASDAQ: CELZ) Major Breakthrough: Allogeneic Cell Line Paves the Way for Diabetes Treatment

Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) has recently seen a substantial intraday gain of over 15% in its share price. Despite the absence of any recent news or filings, this surge could suggest significant progress in the realm of allogeneic cell therapy. Background: The company is known for its regenerative approaches in various medical

Related Keywords

,Greenstone Biosciences Inc ,Creative Medical Technology Immcelz ,Syneos Health ,Creative Medical Technology Holdings Inc ,Master Cell Bank ,Argan Inc ,Creative Medical Technology ,Nasdaq ,Creative Medical Technology Holdings ,Drug Master ,Right Now ,Cell Therapy ,Institutional Review Board ,Orphan Drug Designation ,Medical Technology ,Greenstone Biosciences ,Microcap Daily ,